|
Index of reports
> Cases resulting in death (54)
> Cases with Cardio-Respiratory Arrest (11)
Below is the selection of adverse event reports related to Lorazepam that includes cases resulting in death where reactions include cardio-respiratory arrest.
Adverse event in 39 year old female receiving Lorazepam
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-24
Patient: 39 year old female, weighing 80.7 kg (177.5 pounds)
Adverse reactions / side effects: Refusal of Treatment by Patient, Contusion, Subcutaneous Abscess, Accidental Death, Pleural Adhesion, Fall, Autoimmune Thyroiditis, Drug Toxicity, Cardio-Respiratory Arrest, Hepatomegaly, Cerebral Infarction, Panniculitis, Dehydration, Gastroenteritis Viral, Myocardial Fibrosis
Adverse event resulted in: death
Suspect drug(s):
Soma
Dosage: oral
Administration route: Oral
Indication: Back Pain
Chloral Hydrate
Indication: Insomnia
Diphenhydramine HCL
Indication: Ill-Defined Disorder
Clonazepam
Indication: Ill-Defined Disorder
Diazepam
Indication: Ill-Defined Disorder
Lorazepam
Indication: Ill-Defined Disorder
Methocarbamol
Indication: Ill-Defined Disorder
Tamiflu
Indication: Influenza
Other drugs received by patient: Methadone HCL; Nutropin; Vitamin B-12; Immunoglobulin Injectable; Cipro; Topamax; Acetaminophen; Atropine
Adverse event in 48 year old receiving Lorazepam
Reported by a pharmacist from United States on 2007-03-27
Patient: 48 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Adverse event in 74 year old receiving Lorazepam
Reported by a pharmacist from United States on 2007-03-22
Patient: 74 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Thioridazine HCL
Lorazepam
Acetaminophen W / Codeine (Paracetamol)
Adverse event in 65 year old male receiving Lorazepam
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-26
Patient: 65 year old male
Adverse reactions / side effects: Ultrasound Scan Abnormal, Alanine Aminotransferase Increased, Incorrect Dose Administered, Skin Disorder, High Density Lipoprotein Decreased, Flushing, Haemoglobin Decreased, Glycosylated Haemoglobin Increased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Depressed Level of Consciousness, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Effexor XR
Dosage: 150 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day;sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day;sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df;
End date: 2006-06-11
Tenormin
Dosage: 1000 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day;po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg; po
Administration route: Oral
Multi-Vitamins
Dosage: df;
Adverse event in 65 year old male receiving Lorazepam
Reported by a physician from United States on 2007-02-16
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg qd po
Administration route: Oral
Indication: Depression
Effexor
Dosage: 150 mg daily po
Administration route: Oral
Indication: Depression
Lorazepam
Dosage: 2 mg qd po
Administration route: Oral
Indication: Depression
Trazodone HCL
Dosage: 200 mg qd po
Administration route: Oral
Indication: Depression
Tenormin
Dosage: 100 mg qd po
Administration route: Oral
Indication: Tachyarrhythmia
Lanoxin
Dosage: 0.375 mg qd po
Administration route: Oral
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Glucotrol XL
Dosage: 10 mg qd po
Administration route: Oral
Actos
Dosage: 45 mg qd po
Administration route: Oral
Tricor
Dosage: 160 mg qd po
Administration route: Oral
Lantus
Dosage: 70 qd sc
Start date: 2006-06-09
Lipitor
Vitamin CAP
Risperdal
Dosage: 3 mg po
Administration route: Oral
Adverse event in 31 year old receiving Lorazepam
Reported by a physician from United States on 2007-02-14
Patient: 31 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Mirtazapine
Acetaminophen
Adverse event in 38 year old receiving Lorazepam
Reported by a physician from United States on 2007-02-14
Patient: 38 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Quetiapine Fumarate
Adverse event in 42 year old receiving Lorazepam
Reported by a physician from United States on 2007-02-14
Patient: 42 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Clonazepam
Venlafaxine HCL
Adverse event in 34 year old receiving Lorazepam
Reported by a physician from United States on 2007-02-08
Patient: 34 year old
Adverse reactions / side effects: Cardio-Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Carisoprodol
Oxycodone HCL and Acetaminophen
Adverse event in 65 year old male receiving Lorazepam
Reported by a individual with unspecified qualification from United States on 2007-02-07
Patient: 65 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Pallor, High Density Lipoprotein Decreased, Hepatic Steatosis, Flushing, Haemoglobin Decreased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: Hypercholesterolaemia
Effexor XR
Dosage: 150 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 g q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df
End date: 2006-06-11
Tenormin
Dosage: 100 mg q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg po
Administration route: Oral
Vitamin CAP
Dosage: df
Adverse event in 65 year old male receiving Lorazepam
Reported by a physician from United States on 2007-01-31
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Actos
Dosage: 45 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-07-01
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Effexor
Dosage: 150 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Dosage: 2 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tenormin
Dosage: 100 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage
Dosage: 1000 mg, 2 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Tricor
Dosage: 160 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Lantus
Dosage: see image
Indication: Diabetes Mellitus
End date: 2006-06-09
Lantus
Dosage: see image
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lipitor
End date: 2006-06-11
Multivitamin
End date: 2006-06-11
Risperdal
Dosage: 3 mg, per oral
Administration route: Oral
End date: 2006-06-11
|
